Immune checkpoint inhibitors in advanced cutaneous squamous cell carcinoma: real-world experience from a Canadian Comprehensive Cancer Centre
EC Koch Hein, M Vilbert, I Hirsch, M Fernando Ribeiro… - Cancers, 2023 - mdpi.com
Simple Summary The effectiveness and safety of immune checkpoint inhibitors in the
treatment of patients with advanced cutaneous squamous cell carcinoma were evaluated in …
treatment of patients with advanced cutaneous squamous cell carcinoma were evaluated in …
Cemiplimab in ultra-octogenarian patients with cutaneous squamous cell carcinoma: the real-life experience of a tertiary referral center
Background: The incidence of cutaneous squamous cell carcinoma (cSCC) is rapidly
increasing, paralleling the aging of the population. cSCC predominantly affects chronically …
increasing, paralleling the aging of the population. cSCC predominantly affects chronically …
[HTML][HTML] The side effect registry immuno-oncology (SERIO)–A tool for systematic analysis of immunotherapy-induced side effects
C Ertl, T Ruf, D Mentzer, M Kong, R Kramer… - European Journal of …, 2024 - Elsevier
Background Immunotherapies such as immune checkpoint inhibitors (ICI) are effective in
multiple tumor entities but induce a plethora of side effects. Comprehensive real-world …
multiple tumor entities but induce a plethora of side effects. Comprehensive real-world …
[HTML][HTML] Real-world data on tolerability and clinical response of cemiplimab in patients with advanced cutaneous squamous cell carcinoma: a retrospective …
MW Rohaan, ML Duizer, LA Devriese… - EJC Skin Cancer, 2023 - Elsevier
Background Cutaneous squamous cell carcinoma (CSCC) is the second most common
cutaneous malignancy and patients with advanced disease have a poor prognosis. Phase …
cutaneous malignancy and patients with advanced disease have a poor prognosis. Phase …
Real-world analysis of cost, treatment patterns, and outcomes of patients with metastatic cutaneous squamous cell carcinoma in the US
X Song, CI Chen, G Konidaris… - Expert Review of …, 2023 - Taylor & Francis
Objectives To describe real-world characteristics and treatment patterns of patients with
metastatic cutaneous squamous cell carcinoma (mCSCC). Methods This retrospective …
metastatic cutaneous squamous cell carcinoma (mCSCC). Methods This retrospective …